Pegomas, France

Nathalie Wagner

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nathalie Wagner: Innovator in Doxycycline Formulations

Introduction

Nathalie Wagner is a notable inventor based in Pegomas, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for treating rosacea. Her innovative approach has led to the creation of a unique pharmaceutical composition that enhances the delivery of doxycycline.

Latest Patents

Nathalie Wagner holds a patent for her invention titled "Doxycycline formulations, and methods of treating rosacea." This patent describes a pharmaceutical composition in unit dose form designed for orally delivering doxycycline to humans. The composition includes a capsule coated with a delayed release layer, which contains about 4 to 6 mg of doxycycline monohydrate and a binding agent. The delayed release layer is further coated with an enteric coating that dissolves at a pH of about 5 to 6. Additionally, the immediate release layer comprises about 32 mg of doxycycline monohydrate and a binding agent. The relative mean concentration and area under the curve of the pharmaceutical composition are carefully defined to ensure efficacy after administration.

Career Highlights

Throughout her career, Nathalie has worked with prominent companies in the pharmaceutical industry, including Cerovene, Inc. and Galderma S.A. Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in drug formulation.

Collaborations

Nathalie has collaborated with esteemed professionals in her field, including Jean-Pierre Etchegaray and Manish S. Shah. These collaborations have fostered innovation and have been instrumental in the development of her patented formulations.

Conclusion

Nathalie Wagner's contributions to the pharmaceutical industry, particularly in the formulation of doxycycline for treating rosacea, highlight her innovative spirit and dedication to improving patient care. Her work continues to influence the field and showcases the importance of research and development in pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…